Saint-Gobain has introduced the Gyproc SoundBloc Infinaé 100 plasterboard in the UK, made entirely from recycled materials, marking a world-firs ...
AstraZeneca's Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreate ...
CapMan Real Estate has acquired a brownfield logistics development project near Gothenburg, Sweden, set to replace outdated industrial buildings ...
The New Holland W40X Electric Power, a compact wheel loader, has won the prestigious GOOD DESIGN® award, recognizing its innovative design and a ...
ENGIE has been driving its energy transition strategy since 2021, with significant changes in its asset portfolio, organizational structure, and ...
(IN BRIEF) Saint-Gobain has introduced the Gyproc SoundBloc Infinaé 100 plasterboard in the UK, made entirely from recycled materials, marking a world-first for the company. Developed by British ...
Saint-Gobain has introduced the Gyproc SoundBloc Infinaé 100 plasterboard in the UK, made entirely from recycled materials, marking a world-first for the company. Developed by British Gypsum, the ...
(IN BRIEF) Loughborough Lightning’s Wheelchair Basketball team is set to begin its quest for a fourth consecutive Women’s Premier League (WPL) title on January 18th against Worcester Wolves. Under the ...
(IN BRIEF) AstraZeneca’s Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ...
(IN BRIEF) Ann-Sofie Østberg Bjergby has been appointed as the new Chief Financial Officer (CFO) at NIRAS, effective March 1, 2025. With significant experience in finance, accounting, and M&A, ...
(IN BRIEF) AstraZeneca’s Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ...
(IN BRIEF) AstraZeneca’s Calquence (acalabrutinib) has been approved by the U.S. FDA for the first-line treatment of adult patients with previously untreated mantle cell lymphoma (MCL) who are ...